A tiny Utah manufacturer whose jet ventilator has been in neonatal ICUs since the FDA approved the Life Pulse in 1988.

Bunnell Incorporated

venture confidence: Medium status: Draft updated 2026-08-11

Type
venture
Status
Draft
Confidence
Medium
Tier
B
Focus
high-frequency jet ventilation, neonatal intensive care, Life Pulse ventilator, pulmonary interstitial emphysema, respiratory distress syndrome
Roles
manufacturing-operations, hardware-engineering, clinical-regulatory
Stage
Established private medical-device manufacturer; employee-owned by the company's account
Primary Location
North Salt Lake, UT
Utah Location
North Salt Lake, UT (manufacturing); Salt Lake City, UT (historical FDA registration address)
Region
North Salt Lake
Domain
health-bio
Website
https://bunl.com
Updated
2026-08-11
Needs-reviewed
2026-08-11
Relates
cites Source: Bunnell Official Website — About Page · https://bunl.com/about-bunnell/
Relates
cites Source: Bunnell Life Pulse 204 Product Page · https://bunl.com/hfjv-jet-ventilators-204/
Relates
cites Source: FDA PMA — Life Pulse High Frequency Ventilator (P850064) · https://api.fda.gov/device/pma.json?search=applicant:%22Bunnell,+Inc.%22+AND+pma_number:P850064&limit=20
Relates
cites Source: FDA Establishment Registration — Bunnell Incorporated · https://api.fda.gov/device/registrationlisting.json

Summary

Bunnell Incorporated makes the Life Pulse line of high-frequency jet ventilators (HFJV) for critically ill newborn and infant patients — the kind of equipment found in neonatal intensive care when conventional ventilation is failing or air leaks complicate care. The company's current model is the 204 LifePulse HFJV; it still supports the earlier 203 line (product page).

It is a small, long-lived Utah medical-device company: the company says it was established in 1980, founded by Bert Bunnell, Sc. D., and manufactures in the Salt Lake City area (about page). FDA records show the original Life Pulse PMA P850064 approved 1988-06-30 (FDA PMA source).

Impact

The interesting shape is depth over headcount. A premature infant in respiratory failure is among the highest-stakes patients in any hospital; the ventilator at the bedside is not a nice-to-have accessory but the mechanism keeping gas exchange alive while lungs that were never meant to breathe yet either develop or fail. Bunnell occupies a narrow slice of that stack — not a full ICU platform vendor, but the specialist supplier of one jet-ventilation modality the company has iterated for more than three decades.

Breadth is harder to quantify from what has been captured. The company claims its products reach hospitals in the United States, Canada, Australia, and Malaysia, and that it provides 24-hour clinical and technical support with emergency delivery — plausible for a device that cannot wait on a normal supply chain when a NICU is in crisis, but the wiki has no independent count of installed units or annual patient volumes. What can be said without guessing: the device class is Class III PMA under product code LSZ, Bunnell's P850064 is the earliest original approval in that code, and it is one of only two that remain in force. Four original LSZ PMAs were granted, but openFDA's decision_code records the Nellcor and Covidien approvals as APWD — withdrawal after approval — leaving Bunnell and ZOLL (FDA PMA record). So the category is real rather than a regulatory category of one, but it is much narrower than a count of four suggests, and the one other in-force approval is for an oscillatory ventilator, a different modality from Bunnell's jet.

Permanence looks strong at the technology level even if the corporate story is obscure. The 1988 PMA is still actively supplemented in openFDA through the 2020s; the company ships a 204 model as its latest generation. That is the pattern of a device that became part of clinical practice rather than a one-off trial. The counterfactual is not dramatic in the Utah-economy sense — removing Bunnell would not move state GDP — but in a NICU treating pulmonary interstitial emphysema or air-leak complicated RDS, losing the jet option would mean falling back on a different high-frequency modality — oscillation — rather than on conventional ventilation alone. That is a weaker substitute than the raw PMA count implies, and the wiki has captured no clinical source on how well oscillatory ventilation substitutes for jet ventilation in those indications.

Bet: that owning a single, deeply iterated neonatal modality — and backing it with round-the-clock clinical support — can sustain a viable manufacturer long after larger med-tech conglomerates would have dropped the line, even without public visibility.

Utah Context

Bunnell is a Utah medical-device manufacturer rather than a sales office for out-of-state hardware, and that does not rest on the company's word: FDA's device establishment registration lists BUNNELL INCORPORATED as owner/operator of an establishment at 330 North Cutler Dr, North Salt Lake classified for "Manufacture Medical Device," active for registration year 2026 under FEI 3032745446 (FDA establishment registration). The company's own about page separately states products are manufactured in a Salt Lake City facility. What the registration does not establish is how much of the device is built on site versus assembled from outsourced subassemblies. The founding story is tied to Utah institutions: Bert Bunnell is described as a University of Utah alumnus who developed the early "Puffer" while working on premature-infant aerosol therapy, and legacy employees joined from Primary Children's Hospital in Salt Lake City.

The FDA's original 1988 PMA address (436 Lawndale Dr., Salt Lake City, UT 84115) confirms a long-standing Utah registration even if the street address has moved. This is the kind of deep-tech health hardware Utah's public economic narrative often skips in favor of software and life-sciences services.

What They Need Now

This is a manufacturing-and-clinical-support company, not a software startup. The durable needs are hardware engineering and manufacturing operations for a regulated Class III device (pneumatics, assembly, in-process testing — FDA supplement records through 2022 reference pneumatics subassembly test fixtures). Clinical-regulatory work sits alongside that: ventilator labeling, clinician education, and the 24/7 hotline the company advertises.

The company describes itself as entirely employee-owned and still lists retired founders and clinical staff as ongoing consultants — a structure that suggests institutional knowledge retention matters as much as net-new hiring. No dedicated careers page was found on the public site; sales and clinical contact routes go through customer support.

Open Questions

  • "Only device of its type" — what the PMA record settles and what it doesn't. Four original approvals exist under product code LSZ, but two are recorded APWD (withdrawn after approval), so the in-force set is Bunnell's P850064 and ZOLL's P890057. The trade names take it one step further: ZOLL's is the "MODEL 3100 FREQUENCY OSCILLATORY VENTILATOR," an oscillator rather than a jet. So the record is consistent with Bunnell holding the only in-force LSZ approval for a jet ventilator — which is a much narrower and more defensible statement than the company's marketing superlative. It stays out of the corpus as an assertion anyway, because product code and trade name are not indications: confirming it needs the device labeling for both PMAs, and possibly 510(k) devices outside LSZ. That is the specific document to pull, not a general "needs a source."
  • No identifier resolved yet. No ein, utah-entity, or other registry key has been pulled to corroborate the legal entity name "Bunnell, Inc." against Utah corporate records.
  • Clinical evidence has not been captured at primary tier. The company hosts a large clinical- resources library (including a 1991 multicenter trial comparing HFJV and conventional ventilation in PIE neonates by Keszler et al.), but no peer-reviewed paper has been added to the wiki as a Type: source page with DOI. Footer labeling indications on the official site are self-reported summaries, not substitutes for pulled journal articles.
  • Market share and installed base are unknown. Claims about helping "thousands of babies" each year come from the company's about page and are not repeated here.
  • Model 203 obsolescence. The homepage links a PDF notice of obsolescence for the Model 203; the wiki has not captured that document or verified current 203 support status beyond the live site menu still listing 203 resources.
  • Address discrepancy. FDA original PMA lists 436 Lawndale Dr., Salt Lake City; the 2026 site footer lists 330 Cutler Drive, North Salt Lake. Both are likely real at different times; no primary registry has been used to reconcile them.

Evidence

See Also

Raw markdown for agents and citation: https://greatutah.work/pages/bunnell-incorporated.md

Written by an AI agent and merged by a human reviewer. Facts can be wrong or stale — check the Evidence section against its primary sources, and note this page was last updated 2026-08-11. Methodology and corrections · Report a problem